Following representations from Community Pharmacy England, the Department of Health and Social Care (DHSC) has re-determined that the following products will be granted special container status from 1 May 2025. Generic drug name (dm+d descriptor) Brand and/or Manufacturer Pack size Special container Budesonide 1mg/2ml nebuliser suspension unit dose ampoules Zentiva Pharma UK Ltd 20 unit
Read moreThe Drug Tariff Preface published monthly, lists additions, deletions and other changes to products listed in the Drug Tariff. Below is a summary of the changes coming into effect from 1 May 2025. PART IIIA – Professional fees (pharmacy contractors) Contractors should note the English Pharmacy Contractor Single Activity Fee has changed from £1.27 to £1.46. This was
Read moreFollowing the recent rollout of Electronic Prescription Service (EPS) in detained estates (HM Prisons), NHS England has identified an issue where the patient’s nominated pharmacy details are being populated in the ‘Pharmacy Stamp Area’ of paper FP10 prescriptions and EPS tokens generated by prescribers – i.e. even tokens for non-nominated EPS prescriptions. This section would
Read moreFunding arrangements for community pharmacies, particularly the processes around delivery of retained margin, are not straightforward and it can be difficult for pharmacy owners to predict the impact of any changes on their businesses. This background briefing from Community Pharmacy England’s Funding Team aims to demystify the processes around the distribution and management of margin
Read moreMHRA Class 4 Medicines Defect Notification: Brilique 90mg tablets (G Pharma Ltd) Drug alert number: EL(25)A/18 Date issued: 24 April 2025 The Medicines and Health products Regulatory Agency (MHRA) has issued a class 4 medicines defect information notice for: Brilique 90mg tablets (G Pharma Ltd) as G Pharma Ltd have informed the MHRA that there is
Read moreThe Government is yet to conclude consideration of any increases to prescription charges and NHS prescription pre-payment certificates (PPCs) for 2025/26. Therefore, the current charges will roll over into May 2025. Community Pharmacy England will update community pharmacy teams as soon as any changes are announced by Ministers, including details of when they will be
Read moreThe Department of Health and Social Care (DHSC) has today (22/04/2025) confirmed the following initial list of price concessions for April 2025. Drug Pack size Price concession Alendronic acid 70mg tablets 4 £1.15 Chloramphenicol 1% eye ointment 4 £3.08 Clarithromycin 125mg/5ml oral suspension 70 £6.30 Duloxetine 30mg gastro-resistant capsules 28 £1.99 Duloxetine 60mg gastro-resistant capsules
Read morePaxlovid® (Nirmatrelvir 150mg tablets and Ritonavir 100mg tablets) will be deleted from Part VIIIC of the May 2025 Drug Tariff after confirmation from NHS England (NHSE) that all remaining supplies of this Government procured COVID-19 antiviral medicine will expire on 31 May 2025. The last delivery of Government stock ordered by pharmacies will be on 30 April
Read more
MHRA Class 2 Medicines Notification: Lercanidipine HCl 20mg Tablets (Recordati Industria) Drug alert number: EL(25)A/17 Date issued: 17 April 2025 Recordati Pharmaceuticals Limited has informed the MHRA of an error in the strength of the product printed on some of the faces (sides) of the product carton. The error is limited to one batch of
Read moreCommunity pharmacy owners are being asked to share their views a following the new CPCF funding settlement, ahead of the next full Community Pharmacy England Committee meeting taking place at the end of this month (30th April to 1st May). The new CPCF arrangements mark a pivotal moment for the sector and while the Committee
Read more
